|
1
|
Lu Y, Chopp M, Zheng X, Katakowski M,
Buller B and Jiang F: MiR-145 reduces ADAM17 expression and
inhibits in vitro migration and invasion of glioma cells. Oncol
Rep. 29:67–72. 2013.
|
|
2
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R: Malignant glioma: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
20(Suppl 4): 126–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Che H, Song J, Guo S, Wang W and Gao G:
Inhibition of xenograft human glioma tumor growth by
lentivirus-mediated gene transfer of alphastatin. Oncol Rep.
29:1101–1107. 2013.
|
|
6
|
Delcommenne M, Tan C, Gray V, Rue L,
Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent
regulation of glycogen synthase kinase 3 and protein kinase B/AKT
by the integrin-linked kinase. Proc Natl Acad Sci USA.
95:11211–11216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peroukides S, Bravou V, Varakis J,
Alexopoulos A, Kalofonos H and Papadaki H: ILK overexpression in
human hepatocellular carcinoma and liver cirrhosis correlates with
activation of Akt. Oncol Rep. 20:1337–1344. 2008.PubMed/NCBI
|
|
8
|
Yan Z, Yin H, Wang R, Wu D, Sun W, Liu B
and Su Q: Overexpression of integrin-linked kinase (ILK) promotes
migration and invasion of colorectal cancer cells by inducing
epithelial-mesenchymal transition via NF-κB signaling. Acta
Histochem. 116:527–533. 2014. View Article : Google Scholar
|
|
9
|
Zhao D, Tang XF, Yang K, Liu JY and Ma XR:
Overexpression of integrin-linked kinase correlates with aberrant
expression of Snail, E-cadherin and N-cadherin in oral squamous
cell carcinoma: Implications in tumor progression and metastasis.
Clin Exp Metastasis. 29:957–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hannigan GE, McDonald PC, Walsh MP and
Dedhar S: Integrin-linked kinase: Not so ‘pseudo’ after all.
Oncogene. 30:4375–4385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao Q, Lin C, Gao J, Liang X, Gao W, Shen
L, Kang L and Xu B: Mesenchymal stem cells overexpressing
integrin-linked kinase attenuate left ventricular remodeling and
improve cardiac function after myocardial infarction. Mol Cell
Biochem. 397:203–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alberton CL, Kanitz AC, Pinto SS, Antunes
AH, Finatto P, Cadore EL and Kruel LF: Determining the anaerobic
threshold in water aerobic exercises: A comparison between the
heart rate deflection point and the ventilatory method. J Sports
Med Phys Fitness. 53:358–367. 2013.PubMed/NCBI
|
|
13
|
Serrano I, McDonald PC, Lock F, Muller WJ
and Dedhar S: Inactivation of the Hippo tumour suppressor pathway
by integrin-linked kinase. Nat Commun. 4:29762013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo L, Liu H, Dong Z, Sun L, Peng Y and
Liu F: Small interfering RNA targeting ILK inhibits EMT in human
peritoneal mesothelial cells through phosphorylation of GSK-3β. Mol
Med Rep. 10:137–144. 2014.PubMed/NCBI
|
|
15
|
Yu J, Shi R, Zhang D, Wang E and Qiu X:
Expression of integrin-linked kinase in lung squamous cell
carcinoma and adenocarcinoma: Correlation with E-cadherin
expression, tumor microvessel density and clinical outcome.
Virchows Arch. 458:99–107. 2011. View Article : Google Scholar
|
|
16
|
Min HS, Choe G, Kim SW, Park YJ, Park J,
Youn YK, Park SH, Cho BY and Park SY: S100A4 expression is
associated with lymph node metastasis in papillary microcarcinoma
of the thyroid. Mod Pathol. 21:748–755. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robertson BW and Chellaiah MA: Osteopontin
induces betacatenin signaling through activation of Akt in prostate
cancer cells. Exp Cell Res. 316:1–11. 2010. View Article : Google Scholar
|
|
18
|
Plante I, Charbonneau M and Cyr DG:
Activation of the integrin-linked kinase pathway downregulates
hepatic connexin32 via nuclear Akt. Carcinogenesis. 27:1923–1929.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zong H, Cao L, Ma C, Zhao J, Ming X, Shang
M and Xu H: Association between the G870A polymorphism of cyclin D1
gene and glioma risk. Tumour Biol. 35:8095–8101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou CX and Gao Y: Aberrant expression of
beta-catenin, Pin1 and cyclin D1 in salivary adenoid cystic
carcinoma: Relation to tumor proliferation and metastasis. Oncol
Rep. 16:505–511. 2006.PubMed/NCBI
|
